FDA Label for Mg217 Psoriasis Therapeutic Conditioner
View Indications, Usage & Precautions
Mg217 Psoriasis Therapeutic Conditioner Product Label
The following document was submitted to the FDA by the labeler of this product Wisconsin Pharmacal Company. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Salicylic Acid 3%
Purpose
Psoriasis, Seborrheic Dermatitis, Dandruff Treatment
Uses
For the temporary relief of these symptoms associate with psoriasis, seborrheic dermatitis or dandruff
- itching
- scaling
- flaking,
- reness
- irritaion of the scalp
Helps prevent recurrence.
Warnings
For external use only.
Ask A Doctor Before Use
- if condition covers larger area of body, consult your doctor before using this product.
When Using This Product
- avoid contact wtih the eyes. If contact occurs, rinse thoroughly with water.
Stop Use And Ask A Doctor If
- condition worsens or does not improve after regular use of this product as directed, consult a doctor.
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center Immediately.
Directions
- wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly.
- for best results, use at least twice a week or as directed by a physician.
Inactive Ingredients
Purified water, Sodium laureth sulfate, Cocamidopropyl betaine, Lauryl glucoside, Sodium citrate, Coco-glucoside, Glyceryl oleate, Propanediol, Glycerin, Polyquaterinum-44, Sodium benzoate, Panthenol, Calendula officinalis flower extract, Chamomilla recutita (matricaria) flower extract, Propylene glycol, Citric acid, Chlorhexidine gluconate, Disodium EDTA
Package Label.Principal Display Panel
* Please review the disclaimer below.